Serum IgG2 levels are specifically associated with whole-body insulin-mediated glucose disposal in non-diabetic offspring of type 2 diabetic individuals: a cross-sectional study
Open Access
- 11 September 2018
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 8 (1) , 13616
Abstract
Preclinical studies suggested that IgG2c isotype may specifically impair skeletal muscle insulin sensitivity in mice. In this study we investigated the association between serum levels of the four IgG subclasses and insulin sensitivity in non-diabetic individuals. Total IgG, IgG1, IgG2, IgG3 and IgG4 levels were measured in 262 subjects. Whole-body insulin sensitivity was assessed by euglycemic hyperinsulinemic clamp. IgG2 levels were positively correlated with BMI, waist circumference, 2-h post-load glucose levels and complement C3. Serum IgG2, but not IgG1, IgG3 and IgG4 levels were negatively correlated with whole-body insulin sensitivity (r = −0.17; P = 0.003) and muscle insulin sensitivity index (r = −0.16; P = 0.03) after adjustment for age and gender. No significant correlation was found between IgG2 levels and hepatic insulin resistance assessed by HOMA-IR and liver IR index. In a multivariable regression analysis including variables known to affect insulin sensitivity such as age, gender, BMI, smoking, lipids, inflammatory markers, fasting and 2-h post-load glucose levels, IgG2 levels were independently associated with insulin-stimulated glucose disposal (β = −0.115, 95% CI: −0.541 to −0.024; P = 0.03). These data demonstrate the independent association between higher levels of IgG2 and decreased whole-body insulin sensitivity, thus confirming in humans the animal-based evidence indicating the pathogenic role of IgG2 in insulin resistance.Keywords
This publication has 39 references indexed in Scilit:
- Single-Nucleotide Polymorphism rs7754840 ofCDKAL1Is Associated with Impaired Insulin Secretion in Nondiabetic Offspring of Type 2 Diabetic Subjects and in a Large Sample of Men with Normal Glucose ToleranceThe Journal of Clinical Endocrinology & Metabolism, 2008
- Endothelial Dysfunction and C-Reactive Protein Are Risk Factors for Diabetes in Essential HypertensionDiabetes, 2008
- Control of B-cell responses by Toll-like receptorsNature, 2005
- Complement C3 Is a Risk Factor for the Development of DiabetesDiabetes, 2005
- Toll-like receptors and innate immunityNature Reviews Immunology, 2001
- Toll-like Receptor 2 (TLR2) and TLR4 Differentially Activate Human Dendritic CellsJournal of Biological Chemistry, 2001
- Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.Diabetes Care, 1999
- Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort studyThe Lancet, 1999
- Regulation of human IgG subclass production by cytokines. IFN-gamma and IL-6 act antagonistically in the induction of human IgG1 but additively in the induction of IgG2.The Journal of Immunology, 1994
- Correlation between Serum IgG-2 Concentrations and the Antibody Response to Bacterial Polysaccharide AntigensNew England Journal of Medicine, 1980